drugset
drugset / Trial / NCT05083325

Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product

NCT05083325 ↗

Phase 1 Completed 36 enrolled Laboratorios Andromaco S.A.
RandomizedCrossoverOpen-labelBasic science

Summary

This study will investigate the bioavailability in fasting male and/or non-pregnant and non- breast feeding female subjects of 1 capsule formulation containing Oseltamivir Phosphate 75 mg. The study will be performed at a single site with 36 subjects. Participants will take 1 capsule of the test product and reference product in 2 periods and 2 sequences (either test after reference or reference after test). There will be a washout of at least 2 days between each study period.

Timeline

Start
2021-10-08
Primary completion
2021-10-10
Completion
2021-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule 75 mg —

Indications

No indication recorded.